Governance
HESI is governed by the Board of Trustees, comprised of 16 representatives from the public sector and 14 representatives from the private sector. The Board provides scientific, strategic, and financial oversight for the organization. The HESI Assembly, compromised of public and private sector scientists from HESI’s scientific committees, Trustees, and HESI Emerging Issue Committee Science Advisors, elects the governing Trustees and provides input on new scientific and strategic directions for the organization.
2019-2020 HESI Board of Trustees
Dr. Charlene A. McQueen
President
University of Arizona
Dr. Lois Lehman-McKeeman
Chair
Bristol-Myers Squibb Company
Dr. Jon C. Cook
Vice President
Pfizer, Inc.
Dr. Martin van den Berg
Vice Chair
Utrecht University
Dr. Greg Adamson
Givaudan Fragrances Corporation
Dr. Scott E. Belanger
The Procter & Gamble Company
Dr. Stuart Cagen
Shell Health
Prof. Alan Boobis
Imperial College London
Dr. Warren M. Casey
National Institutes of Environmental Health Sciences
Dr. David L. Eaton
University of Washington
Dr. Patrick D. Guiney
University of Wisconsin
Dr. Ernie Harpur
Newcastle University
Dr. Anthony Holmes
National Centre for the Replacement, Refinement and Reduction of Animals in Research
Dr. Tim Kedwards
S.C. Johnson & Son, Inc.
Dr. Jerry S.H. Lee
Lawrence J. Ellison Institute for Transformative Medicine of USC
Dr. Maya Leventer-Roberts
Icahn School of Medicine at Mount Sinai
Dr. José E. Manautou
University of Connecticut
Dr. Gary Minsavage
Exxon Mobil Corporation
Dr. Graeme Moffat
Amgen, Inc.
Dr. Marc Pallardy
Université Paris-Sud
Dr. Timothy P. Pastoor
Boragen
Dr. William Pennie
Takeda Pharmaceutical Company Limited
Dr. Martin A. Philbert
University of Michigan
Dr. Stefan J. Platz
AstraZeneca Pharmaceuticals LP
Dr. Nathan D. Price
Institute for Systems Biology
Dr. Ruth Roberts
ApconiX Ltd.
Dr. Pamela J. Spencer
The Angus Chemical Company
Dr. Yuko Sekino
University of Tokyo
Dr. Clifford P. Weisel
Rutgers University
Dr. Douglas Wolf
Syngenta
